CASP3 and cancer: In Stage III CRC, the ability of cancer cells to activate Caspase-3 in response to chemotherapy, as determined by a quantitative analysis of all components of the mitochondrial apoptosis pathway in their inactive state, has been associated with good outcome in CRC (33, 34).